Daniel Dornbusch

CEO at Excision BioTherapeutics

Daniel Dornbusch has worked in the biotechnology industry for over 20 years for large pharmaceutical, small biotechnology, and diagnostics companies in roles including business development, mergers and acquisitions, marketing, sales, commercial strategy, and product development. He most recently served as founder and CEO of Acteris, an immunoncology company located in San Francisco. Daniel previously served as Chief Commercial Officer at Nodality, a therapeutic development company focused in immunology, oncology and immunoncology. Before Acteris, Daniel worked at Novartis in business development and later assumed responsibility as the Commercial Director of the Western United States and Latin America for the Diagnostics Division. Previous to Novartis, Daniel held roles in business development at Cerimon Pharmaceuticals, led business development and sales for NMCR, an oncology strategy arm of AmerisourceBergen, and led a hematology marketing team at Genentech.

Daniel started his biotechnology career at the Genzyme Corporation and served in various roles including business development, product management, and corporate development. Daniel received his B.A. in Biology and English from Cornell University, M.S. from Tufts University School of Medicine and Emerson College, and M.B.A. from the Harvard Business School.

Links

Previous companies

Novartis logo

Timeline

  • CEO

    Current role

View in org chart